Caprock Group LLC Has $732,000 Stock Position in Unum Group (NYSE:UNM)

Caprock Group LLC raised its holdings in Unum Group (NYSE:UNM) by 1.8% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 12,308 shares of the financial services provider’s stock after buying an additional 221 shares during the quarter. Caprock Group LLC’s holdings in Unum Group were worth $732,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Versant Capital Management Inc increased its stake in shares of Unum Group by 361.5% in the 2nd quarter. Versant Capital Management Inc now owns 503 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 394 shares in the last quarter. V Square Quantitative Management LLC acquired a new stake in Unum Group in the second quarter worth $26,000. 1620 Investment Advisors Inc. bought a new stake in Unum Group in the second quarter valued at $29,000. Capital Performance Advisors LLP acquired a new position in shares of Unum Group during the third quarter valued at about $31,000. Finally, Thurston Springer Miller Herd & Titak Inc. acquired a new position in shares of Unum Group during the third quarter valued at about $37,000. 86.57% of the stock is currently owned by institutional investors.

Unum Group Stock Up 0.5 %

Unum Group stock opened at $75.83 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.28 and a current ratio of 0.28. The stock has a market cap of $13.85 billion, a PE ratio of 8.21, a price-to-earnings-growth ratio of 1.06 and a beta of 0.76. Unum Group has a fifty-two week low of $41.97 and a fifty-two week high of $76.31. The firm’s 50-day simple moving average is $63.45 and its 200 day simple moving average is $56.49.

Unum Group (NYSE:UNM) last announced its earnings results on Tuesday, October 29th. The financial services provider reported $2.13 earnings per share for the quarter, topping analysts’ consensus estimates of $2.10 by $0.03. The firm had revenue of $3.22 billion for the quarter, compared to the consensus estimate of $3.26 billion. Unum Group had a return on equity of 15.21% and a net margin of 13.76%. The company’s revenue was up 4.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.94 EPS. Research analysts predict that Unum Group will post 8.53 EPS for the current fiscal year.

Unum Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 25th were paid a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.22%. The ex-dividend date was Friday, October 25th. Unum Group’s payout ratio is 18.18%.

Unum Group declared that its Board of Directors has approved a share repurchase plan on Tuesday, July 30th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the financial services provider to reacquire up to 10% of its shares through open market purchases. Shares buyback plans are often a sign that the company’s board of directors believes its shares are undervalued.

Wall Street Analyst Weigh In

UNM has been the subject of a number of research analyst reports. Wells Fargo & Company boosted their target price on Unum Group from $69.00 to $71.00 and gave the company an “overweight” rating in a research report on Thursday, October 10th. UBS Group upgraded Unum Group to a “hold” rating in a report on Wednesday, October 9th. Evercore ISI upgraded Unum Group from an “in-line” rating to an “outperform” rating and increased their target price for the stock from $67.00 to $84.00 in a report on Thursday, November 14th. Truist Financial boosted their price target on shares of Unum Group from $70.00 to $75.00 and gave the company a “buy” rating in a research note on Friday, November 1st. Finally, Bank of America raised their price objective on shares of Unum Group from $54.00 to $63.00 and gave the company a “neutral” rating in a research note on Thursday, October 10th. Four equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat.com, Unum Group presently has an average rating of “Moderate Buy” and an average target price of $67.73.

Insider Transactions at Unum Group

In related news, Director Gloria C. Larson sold 10,000 shares of Unum Group stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $74.50, for a total value of $745,000.00. Following the sale, the director now owns 121,491 shares of the company’s stock, valued at approximately $9,051,079.50. The trade was a 7.61 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Lisa G. Iglesias sold 5,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 20th. The shares were sold at an average price of $72.61, for a total value of $363,050.00. Following the completion of the transaction, the executive vice president now owns 35,840 shares in the company, valued at approximately $2,602,342.40. The trade was a 12.24 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 165,709 shares of company stock worth $10,956,914 in the last ninety days. Company insiders own 0.93% of the company’s stock.

Unum Group Profile

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.